Some providers reduce the dose while maintaining daily frequency
and T.P
Many of these variations arise from genetic differences in hormone programming or metabolism
However, by reducing intense hunger and sugar cravings, GLP-1s make it easier to eat less without feeling deprived
To view or add a comment, sign in What happens when a clinical trial needs to shift midstream
GLP-1 drug usage was associated with a reduced risk of just about everything bad: substance use and psychotic disorders, seizures, neuro-cognitive disorders (including Alzheimers disease and dementia), coagulation disorders [e.g., means clotting], cardio-metabolic disorders, infectious illnesses and several respiratory conditions. When I initially read this study in January, it seemed too good to be true